- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2012
- Public Summary Document (PSD) July 2012 PBAC Meeting - PDF
Trastuzumab – July 2012
Trastuzumab, powder for I.V. infusion, 60 mg and 150 mg, Herceptin®
Last updated
8 November 2023